AstraZeneca Pharma India informs about Press Release

30 May 2015 Evaluate

AstraZeneca Pharma India has informed about Press Release dated May 29, 2015 titled ‘AstraZeneca Pharma India Limited and Dr Reddy’s Laboratories Limitedenter distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes’.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8908.70 -254.05 (-2.77%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×